Mon, October 11, 2021
Sun, October 10, 2021
Fri, October 8, 2021
Thu, October 7, 2021
Wed, October 6, 2021
Tue, October 5, 2021
Mon, October 4, 2021
Sun, October 3, 2021
Fri, October 1, 2021
Thu, September 30, 2021
Wed, September 29, 2021
Tue, September 28, 2021
Mon, September 27, 2021
Sun, September 26, 2021
Fri, September 24, 2021

Esther Rajavelu Upgraded (ALNY) to Strong Buy and Increased Target to $215 on, Oct 4th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-215-on-oct-4th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Esther Rajavelu of UBS, Upgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Strong Buy and Increased Target from $141 to $215 on, Oct 4th, 2021.

Esther has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 2 agree with Esther's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gary Nachman of "BMO Capital" Maintained at Hold with Increased Target to $196 on, Friday, August 27th, 2021
  • Edward Tenthoff of "Piper Sandler" Downgraded from Buy to Hold and Held Target at $181 on, Wednesday, August 4th, 2021


These are the ratings of the 3 analyists that currently disagree with Esther


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $250 on, Friday, August 13th, 2021
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $216 on, Wednesday, August 4th, 2021
  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $234 on, Wednesday, August 4th, 2021